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ABSTRACT
Aspartame is an artificial sweetener much like high fructose corn syrup but is
synthetically made compared to being derived from a naturally occurring compound.
Many diet beverages and foods contain this chemical since it is about 200 times sweeter
than regular table sugar and contains very few calories. Some people with a hereditary
disease cannot metabolize the phenylalanine resulting from the breakdown of the
aspartame. This, and potential health risks, have caused widespread controversy
regarding the FDA approval of aspartame. I have used High Performance Liquid
Chromatography (HPLC) to quantify the amount of aspartame present in Diet Coke and
Diet Dr. Pepper. I investigated how elevated temperatures can cause aspartame to become
unstable and breakdown into potentially toxic chemicals. These findings will promote the
labeling of actual amounts present in each drink, similar to how caffeine is labeled.
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INTRODUCTION
Aspartame is a synthetic sweetener known by the trade name Nutrasweet® that has been
FDA approved since 1981.1 It is currently sold in over one hundred companies, with more
than 250 million people consuming this chemical. Public concern over aspartame’s
toxicity has caused this chemical to be one of the most researched compounds used in
food products. This substance is a member of the aniline group and is made of two amino
acids – phenylalanine and aspartic acid, as well as methyl alcohol, more commonly
known as methanol or wood alcohol. Studies have been and continue to be conducted on
the safety, manufacturing, and quantification of aspartame as well as the adverse effects
on people who have certain allergies to phenylalanine, a compound that is broken down
from aspartame in the body. Main categories that are expanded in research include the
use of aspartame in place of other artificial sweeteners along with the role of this
chemical in diet and/or sugar-free foods. Almost any type of chewing gum found in the
United States contains aspartame; since most diet sodas contain aspartame, a new
problem that has occurred is when these companies replace aspartame with saccharin or
other sweeteners in their diet beverages. Before switching fully to the new artificial
sweetener, they will continue to use aspartame but have bottled their product in new
labelling.2 This situation can cause a major concern for people who are trying to avoid
phenylalanine and aspartame, and can also be problematic in a legal standing.
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HISTORY
Aspartame was originally discovered in a research laboratory owned by G.D. Searle in
1965. James Schlatter was working on synthesizing a tetrapeptide to block a
gastrointestinal hormone.1 During one step of the synthesis, Mr. Schlatter was
recrystallizing the aspartylphenylalanine methyl ester (aspartame) and accidentally got
some of the substance on his fingers. Later on during the experiment he went to lick his
finger to pick up a paper and noticed a strong sweet taste. With this accidental discovery,
a new low-calorie, artificial sweetener was created. It has 150-200 times the sweetness of
sucrose and does not have the bitter aftertaste that other artificial sweeteners are known
for.
The Searle company owned the rights to aspartame until they were bought out by
Monsanto in 1985, two years after the FDA approved aspartame for use in carbonated
beverages.3 For some consumers, they are wary when they hear that Monsanto, a
company known for producing a series of powerful pesticides, bought out the company
that created a popular artificial sweetener. This ownership did not affect what aspartame
was known for or used for in the following years. In 2000 Monsanto sold the Nutrasweet
brand name to J.W. Childs Equity Partners. Production of aspartame has continued to the
present with this company.4
Aspartame is created using two amino acids L-phenylalanine methyl ester and L-aspartic
acid. These amino acids are not known to be sweet so the taste of aspartame was not
something predicted. Only the LL diastereoisomer contained the sweetness; LD, DL, and
DD were slightly bitter.5 When L-phenylalanine and L-aspartic are coupled, they create
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the dipeptide methyl ester. If this is done chemically for reproduction purposes, there will
be two types of aspartame present in the final product: α-aspartame and β-aspartame.
Only the alpha (α) form contains the intense sweetness.1 In all my research, I was unable
to find the difference between the two types besides the sweetness. This chemical is
approximately 40% aspartic acid and over half of the aspartame molecule is
phenylalanine.5 Phenylalanine is an essential part of our daily intake since we cannot
synthesize it ourselves. A small amount of phenylalanine is essential for survival but
these values differ for each person. In this case, aspartame does provide an amino acid
that we use in many bodily functions, however, phenylalanine can be absorbed when
eating proteins including meat.
Unless it is exposed to aqueous solutions, aspartame is very stable and only breaks down
when exposed to elevated temperatures.1 According to the MSDS all potential chronic
health effects (carcinogenic, mutagenic, teratogenic and developmental toxicity) are not
available.6
There are many various ways to detect aspartame in food and drink, both qualitatively
and quantitatively. Most researchers agree that identifying aspartame quantitatively is a
more productive mean than just identifying aspartame that is present in the substance.
The two main ways to determine quantitative and qualitative measurements is through the
use of absorption spectra and Chromatography techniques using various instruments.
Some are more efficient than others, and yet still others contain factors that may hinder
the accuracy of the results.2 High Performance Liquid Chromatography (HPLC) is the
technique most commonly used and the Center for Disease Control (CDC) has used this

9

technique for their procedure on quantifying the aspartame. In the research section of this
thesis, I will modify their procedure to fit my own analysis.
In the 1970s, various researchers from the Food and Drug Administration (FDA)
estimated that the maximum consumption of aspartame to be anywhere from 22-34
mg/kg of body weight (bw) per day. So for a 140 pound person, a range of 1,397- 2,159
mg of aspartame could be consumed in a single day. Now this information is based on
replacing all sucrose with aspartame in this person’s diet. The actual daily consumption is
less than that.1 Currently the FDA has allotted 50 mg/kg bw per day as the Allotted Daily
Intake (ADI). For a 150 lb. person, this would equate to roughly 3400 mg of aspartame in
a single day.
There has been little research done on how fast aspartame breaks down in aqueous
solutions. The research that has been done focuses on toxicity and possible neurological
problems arising from the intake of aspartame in various mammals including humans.5
All of the results presented to the FDA have stemmed from the original controversy
surrounding the FDA’s approval of aspartame.

CONTROVERSY
Originally, the FDA approved aspartame in 1974 for dry foods. After an in depth analysis
of the fifteen studies the Searle’s research team conducted, there was a proposed
hypothesis that aspartame could have the potential to cause brain tumors based upon rat
studies.1 For the first time in FDA history, an independent group of scientists evaluated a
complaint against an FDA approved substance. A Public Board of Inquiry was created to
10

handle this issue. The approval was revoked by the board because of questionable
practices done by the Searle’s research team. Searle’s company had been fighting to get
FDA approval and the methods they used to present their findings were deemed
inconsistent.
In January of 1981, Ronald Reagan took office and with him, Dr. Arthur Hull Hayes Jr.
was selected to be the new FDA Commissioner by Donald Rumsfeld, CEO of G.D.
Searle and former secretary of defense. A commissioner’s panel was established after the
ruling from the Public Board of Inquiry. Dr. Hayes played a key role in the passing of
aspartame. Not only did he personally appoint a sixth member to the commissioner’s
panel to tie the vote, he also made the tie breaking decision. This was how the FDA
approved the use of aspartame in dry goods in 198.7 Soon after, a petition was put in to
approve aspartame in the use of diet sodas. In 1983 the FDA approved aspartame for the
use in carbonated beverages. In a hearing before the committee on labor and human
resources, the health and safety concerns of aspartame were examined. In this discussion
it was mentioned that over 3,500 complaints regarding soft drink consumption were
analyzed.8
Aspartame breaks down into aspartic acid, phenylalanine, and methanol. From there
further degradation occurs and formaldehyde and formic acid are produced. According to
the Environmental Protection Agency (EPA) formaldehyde is classified as a probable
carcinogen when high or long exposures occur with humans. While aspartame is one of
the most thoroughly tested additives of all time, these products have been shown to cause
harm to humans.9
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One of studies first presented to the FDA during the approval process had shown that rats
given large doses of aspartame had elevated cancer rates than control rats. This was
brought into the public’s eye in the 1970s. Another study, conducted by the G.D. Searle
research team, followed behavioral patterns of neonatal monkeys that were given large
doses (0-3 g aspartame/kg bodyweight). These scientists were looking for seizure
susceptibility increasing from the chemical. While the monkeys showed no difference
between the control group as stated in the hearing for the Labor and Human Resources
Committee, nothing was stated about the physical conditions of the monkeys.8 According
to Rich Murray, out of the seven monkeys fed aspartame, one died and two others did not
finish the prescribed number of days of testing.3,10 While nothing this severe has appeared
in humans, other symptoms that can cause problems have been reported.

H.J. Roberts, an M.D., has been monitoring people’s health over the years. His focus was
on hypoglycemia or low blood sugar attacks and originally believed that aspartame was a
useful product to give his patients. One of his patients named Tammy began to follow his
directions when he identified hypoglycemia to be her problem with strange convulsions.
After putting her on a set schedule of food to stop the hypoglycemic attacks from
occurring, she began to have a seizure. He was then informed that some of the food he
was having her take contained aspartame in it. After being told that her grandmother had
adverse reactions to aspartame, he was able to identify that aspartame was the culprit.
The seizures stopped altogether after removing aspartame from her diet.9 H.J. Roberts has
had problems finding information about these adverse side effects when consuming
aspartame. From my own literary research, there are very few journals that contained
12

information on the hazards of aspartame. Most of these findings state that aspartame is
inherently safe for human consumption and that there can be side effects in individuals
who have Phenylketonuria (PKU) also known as Folling’s disease. This is a genetic
disorder where the human body is unable to break down phenylalanine.
According to H.J. Roberts, women outweigh men when reporting complaints about
aspartame. It is unknown if this is just that more women have added complaints to the
FDA or whether there are more women affected by aspartame. Another angle could be
that more women use diet or sugar-free foods and beverages than men. This author adds
many examples and quotes from people he has interviewed based upon the information
provided by the FDA.9
One of the largest complaints to the FDA when consuming aspartame-laden food and
beverages is the onset of headaches. Many of the manufacturers of Nutrasweet® have
pointed to scientific studies that discredit this complaint. One of these studies was
conducted by Dr. Susan S. Schiffman. They had 40 participants that had previous
symptoms when exposed to aspartame. Her results found no difference between
headaches occurring in patients that ingested aspartame versus those that ingested a
placebo. When these findings were published, this became a topic for debate. The
capsules used to provide the aspartame are only able to be 50% absorbed which can skew
the resulting data and that the phenylalanine present in blood levels was not measured.11
Most studies that were conducted in the early years after the FDA approval of aspartame
were on animal subjects. This in itself can be a possible flaw in the study since testing did
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not occur on the actual species in question. I am not stating that we should only do human
testing, but some animal testing could be less reliable for human research.
The writers who are against aspartame rely heavily on consumer complaints and
testimonies regarding their own reactions with aspartame. On the other side, B. A.
Magnuson who has critically evaluated this artificial sweetener according to the FDA’s
maximum ADI and human subjects for testing. Overall he found that 90% of people do
not have any adverse reactions towards aspartame-laden products.1 The FDA also reports
that individuals can have adverse reactions to any compound and since the majority of
people do not have such reactions, that this compound is safe for human consumption.12
The common theme occurring in these cases is that the individual did consume large
amounts of aspartame before their symptoms began. Once they stopped their intake, the
symptoms either disappeared or gradually left the person. Since there are roughly 1 in
15,000 people who have the genetic disease PKU, these cases may be related to the
disease.9 In the seizure example stated previously, it was found out that the young girl did
have phenylalanine allergies in her family history and this was the apparent cause of her
reaction. Not all of the examples given for these reactions contained information on the
patient’s family history. In general, most of the examples of problems with aspartame
were caused by an abnormally large consumption of food and beverages containing the
aspartame. This could be in the range of 5+ diet drinks, and additional food items that
also contained aspartame per day. Each individual person will react differently to
aspartame; some will have no reaction, some will have severe reactions, and others may
have slight issues.
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It is easy to find many articles and books written on the problems that aspartame has
caused, however, there are others that have conclusions where aspartame is not inherently
bad for human consumption. The people most easily susceptible to the aspartame
reactions are ones who have PKU. These people not only need labels on items that
contain phenylalanine, but they should also have the amounts present in the item as well.
Currently, the amount of aspartame present in pharmaceuticals is labelled. I believe that
this should become a requirement for food and beverage labels as well so that consumers
will be able to identify just how much aspartame they are consuming in a day.

ASPARTAME AND HEAT PROCEDURE I :
Introduction:
This experiment is used to determine the concentrations of aspartame present in two
major diet sodas: Diet Pepsi and Diet Dr. Pepper while being exposed to elevated and
room temperatures.
Theory:
According to multiple sources, aspartame breaks down into three chemicals when
exposed to high temperatures: aspartic acid, methyl alcohol, and phenylalanine. This
experiment will serve to test this hypothesis and the results will identify just how much
breakdown occurs.
A simple calibration curve is constructed using known concentrations of aspartame in
water. The overall area is taken from each of the aspartame peaks of bottle and can
15

samples for both control and test. These numbers are then used in the calibration curve
equation to calculate a concentration.
According to a source13, roughly 125 mg and 123 mg of aspartame is present in 8 fluid
ounces of diet Coke and diet Dr. Pepper respectively. From my calculations, the
concentrations should be roughly 1.79*10-3 mol/L and 1.77*10-3 mol/L for each of the
samples. This will be the concentration I will be looking for when testing occurs. If the
concentration is less for the heated samples then I will assume that the high temperatures
degraded the aspartame samples; if the concentrations are higher, more tests will need to
be run before any action can be taken to let the Coke Company know their figures are off
regarding the amount of aspartame present in their diet soft drinks.
A procedure provided by the CDC was used to create the procedure for the quantification
of aspartame. The CDC’s procedure called for a flow rate of 1-3 L/min. This was
changed to 2 mL/min.14
Equipment:
Hitachi L-4250 UV-VIS Detector HPLC
Hitachi L-6200 Intelligent Pump
Thermo Scientific Heratherm OGS100 General Lab Oven
Parafilm
(2) 1 L Erlenmeyer flasks
(1) 1 L volumetric flask
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(8) 150 mL beakers
(2) 50 mL graduated cylinders
(1) funnel
Metal spatulas
Rubber stoppers
Stir bar
pH meter
Vacuum
Corks

Reagents:
1. Aspartame
2. Water, deionized
3. Acetonitrile
4. Methanol
5. 1-Heptanesulfonic acid sodium salt (Reagent for Ion-Pair Chromatography)
6. Monobasic potassium phosphate
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7. Phosphoric acid

Procedure:
Each of the 8, 150 mL beakers was labelled according to what sample they contained
(diet Coke can, diet Coke bottle, diet Dr. Pepper can, and diet Dr. Pepper bottle). All diet
soda containers were decarbonated before testing began. Two beakers were filled with
100 mL of diet Coke from a can and covered with Parafilm. This was repeated with diet
Coke from a bottle, and diet Dr. Pepper from a can and a bottle. One of each sample was
placed into a Heratherm OGS100 General Lab Oven set at 50 °C. The other four samples
were left at room temperature. Samples were subjected to these temperatures for 37 days.
To create Eluent A: 2.062 g of 1-Heptanesulfonic acid sodium salt and 0.453 g
monobasic potassium phosphate were added to 1 L of deionized water. The pH was
originally 4.6 but was adjusted to 2.6 using diluted phosphoric acid.
To create Eluent B: 2.063 g of 1-Heptanesulfonic acid sodium salt to 1 L of a 3:2 (v/v)
acetonitrile-water solution. The pH was adjusted to 3.1 using diluted phosphoric acid.
Because of the various chemicals being run through the HPLC, the system was purged
using HPLC-grade methanol for 30 minutes before any experimentation began. Then I
repurged the system using the Eluent A and B before standards were run. The mobile
phase consisted of 60/40 Eluent A to Eluent B. Since only one of our solvent tubes is
working properly, I had to mix the two eluents together to create the mobile phase.
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The mobile phase was degassed before being used and a flow rate of 2.00 ml/min was
used. To make sure the concentrations were not too high or too low 1.7*10-4 M of
aspartame was tested as a standard. 10 µL of standard was injected into the system. I let
the system run for ten minutes and no variation from zero occurred. Instead a higher
concentration of aspartame (0.005 M) was made. This again provided no results so this
procedure was scrapped altogether and a new procedure that has been used in a previous
chemistry lab was used.
Calculations:
I found the amount of aspartame present in 8 fluid ounces of both diet Coke and diet Dr.
Pepper and used this data to calculate the estimated concentration of aspartame in a 12 oz
can and a 16.9 oz bottle of diet soda.
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Diet Coke

8 fl. oz.

125 mg

12 fl. oz. can

187.50 mg

16.9 fl. oz. bottle

264.06 mg

Concentration (M)

1.79*10-3

Diet Dr. Pepper
8 fl. oz.

123 mg

12 fl. oz. can

184.5 mg

16.9 fl. oz. bottle

259.84 mg

Concentration (M)

1.77*10-3
Table 1

Given these values, I was able to calculate a rough estimate on the concentration of
aspartame in both Diet Coke and Diet Dr. Pepper: 1.79*10-4 mol/L and 1.77*10-4 mol/L
respectively.
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Results
As you can see from the screenshots captured, there was no logical data collected.
Originally data corresponding to retention time and voltage was being collected and the
peak area and retention time would be used to identify aspartame. The data being
collected not match with the provided aspartame peak so therefore the data was
inconclusive. Eventually continuous runs provided no results whatsoever as shown in the
last two screenshots. This was deemed a failure and another procedure was used to
complete the experiment.
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Figure 1:
22

Figure 2
This is the graph of 0.005 M of aspartame. Instead of nice distinct peaks, what looks like
a seismograph was instead recorded.
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Figure 3
This screenshot shows that after 20 minutes of running the 0.005 M aspartame solution
through the HPLC, there were no peaks and no data was collected.
POSSIBLE ERRORS
Age of monobasic potassium phosphate
Having to mix Eluent A and B to create the mobile phase
Age of aspartame
Wrong procedure used for the HPLC accessible
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ASPARTAME AND HEAT PROCEDURE II:
Theory:
The theory is identical to the previous procedure. This is a new procedure to be used in
the experiment.

Equipment:
Hitachi L-4250 UV-VIS Detector HPLC
Hitachi L-6200 Intelligent Pump
Thermo Scientific Heratherm OGS100 General Lab Oven
Parafilm
Stir bars
10 mL beakers
0.45 µm ptfe filters
syringe
Procedure
Before any samples or standards were run, the HPLC was set to have a flow rate of 1.5
mL/min and the detector wavelength was set to 254 nm.15 A mobile phase of 80/20 1 M
acetic acid and methanol was made and degassed before being used to purge the HPLC
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column. 0.200 g of aspartame was added to 100 mL the 80/20 mobile phase. 10 µL of
this solution was injected into the HPLC and the peak was recorded as Standard 1. Four
standards were created as shown in Table 3 and 10 µL of each standard was injected into
the HPLC. Two tests were run for each sample and the corresponding areas were
averaged to create a calibration curve.
Each of the 8, 150 mL beakers was labelled according to what sample they contained
(diet Coke can, diet Coke bottle, diet Dr. Pepper can, and diet Dr. Pepper bottle). All diet
soda containers were decarbonated before testing began. Two beakers were filled with
100 mL of diet Coke from a can and covered with Parafilm. This was repeated with diet
Coke from a bottle, and diet Dr. Pepper from a can and a bottle. One of each sample was
placed into a Heratherm OGS100 General Lab Oven set at 50 °C. The other four samples
were left at room temperature. Samples were subjected to these temperatures for 37 days.
Roughly 6 mL of each of the 8 samples were filtered through 0.45 µm PTFE-membrane
filters before 10 µL of solution was injected into the HPLC. Following the procedure, the
aspartame peak should appear around 5-7 minutes if the mobile phase pH is 3-5.

26

Key Abbreviations
DCC – Diet Coke Can
DCB – Diet Coke Bottle
DDPC – Diet Dr. Pepper Can
DDPB – Diet Dr. Pepper Bottle
DCCH – Diet Coke Can Heat
DCBH – Diet Coke Bottle Heat
DDPCH – Diet Dr. Pepper Can Heat
DDPBH - Diet Dr. Pepper Bottle Heat

Calculations
Calculating standard molarity:
1
(

𝑔
𝑚𝑜𝑙)∗(0.100 𝐿)
0.200 𝑔

294.31

= 6.80*10 -3 mol/L

Calculating sample concentration using calibration curve:
𝑦 = 22788𝑥
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Sample DCC peak area = 26.51 mV*s
26.51 = 22788𝑥
x = 0.001163 mol/L
Calculating mg aspartame/can
𝑚𝑜𝑙

= 1.163 ∗ 10−3 (

𝐿

𝑔

𝑚𝑔

) ∗ 294.31 (𝑚𝑜𝑙 ) ∗ 1000 (

𝑔

𝐿

𝑓𝑙.𝑜𝑧

) ∗ 0.029574 (𝑓𝑙.𝑜𝑧.) ∗ 12 ( 𝑐𝑎𝑛 )

= 121.47 mg/can
Sample DCCH peak area = 4.66 mV*s
4.66 = 22788𝑥
x = 0.000204 mol/L
Calculating mg aspartame/can heat
𝑚𝑜𝑙

= 2.04 ∗ 10−4 (

𝐿

𝑔

𝑚𝑔

) ∗ 294.31 (𝑚𝑜𝑙) ∗ 1000 (

𝑔

𝐿

𝑓𝑙.𝑜𝑧

) ∗ 0.029574 (𝑓𝑙.𝑜𝑧.) ∗ 12 ( 𝑐𝑎𝑛 )

= 21.31 mg/can
Sample DDPB peak area = 38.54 mV*s
38.54 = 22788𝑥
x = 0.001691 mol/L
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Calculating mg aspartame/bottle heat
𝑚𝑜𝑙

= 1.691∗ 10−3 (

𝐿

𝑔

𝑚𝑔

) ∗ 294.31 (𝑚𝑜𝑙 ) ∗ 1000 (

𝑔

𝐿

𝑓𝑙.𝑜𝑧

) ∗ 0.029574 (𝑓𝑙.𝑜𝑧.) ∗ 16.9 (𝑏𝑜𝑡𝑡𝑙𝑒)

= 248.74 mg/bottle
Sample DDPBH peak area = 6.1 mV*s
6.1 = 22788𝑥
x = 0.000268 mol/L
Calculating mg aspartame/bottle heat
𝑚𝑜𝑙

= 2.68∗ 10−4 (

𝐿

𝑔

𝑚𝑔

) ∗ 294.31 (𝑚𝑜𝑙 ) ∗ 1000 (

𝑔

𝐿

𝑓𝑙.𝑜𝑧

) ∗ 0.029574 (𝑓𝑙.𝑜𝑧.) ∗ 16.9 (𝑏𝑜𝑡𝑡𝑙𝑒)

= 39.42 mg/bottle
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Results
Standard

1

Retention time

Concentration

Area

Avg. Area

(min)

(M)

(mV*s)

(mV*s)

9.55

6.8*10-3

9.03
2

7.71

7.31

5.0*10-4

7.64

21.365

16.863

12.361
5.0*10-3

6.74
4

158.447

162.753

7.81
3

154.141

57.152

109.098

161.044
1.0*10-3

7.62

21.055

20.514

19.973
Table 2
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Samples

Retention Time

Area (mV*s)

(min)

Concentration

Concentration

(M)

(mg/can or
mg/bottle)

DCC

7.62

26.51

0.001163

121.47

DCB

7.59

29.71

0.001304

191.81

DDPC

7.58

25.92

0.001137

118.76

DDPB

7.44

38.54

0.001691

248.74

DCCH

7.80

4.66

0.000204

21.31

DCBH

7.80

3.72

0.000163

23.98

DDPCH

6.80

184.13

0.008080

843.93

DDPBH

7.78

6.1

0.000268

39.42

Table 3
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Standard Results

Figure 4: Standard 1 Run 1 Chromatogram

Figure 5: Standard 1 Run 1 Result Table
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Figure 6: Chromatogram of Standard 1 Run 2

Figure 7: Standard 1 Run 2 Result Table
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Figure 8: Standard 2 Run 1 Chromatogram

Figure 9: Standard 2 Run 1 Result Table

34

Figure 10: Standard 2 Run 2Chromatogram

Figure 11: Standard 2 Run 2 Result Table
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Figure 12: Standard 3 Run 1 Chromatogram

Figure 13: Standard 3 Run 1 Result Table
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Figure 14: Standard 3 Run 2 Chromatogram

Figure 15: Standard 3 Run 2 Result Table
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Figure 16: Standard 4 Run 1 Chromatogram

Figure 17: Standard 4 Run 1 Result Table
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Figure 18: Standard 4 Run 2 Chromatogram

Figure 19: Standard 4 Run 2 Result Table
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Figure 20: Standard 4 Run 3 Chromatogram

Figure 21: Standard 4 Run 3 Result Table
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Sample Results

Figure 22: Diet Coke Can Chromatogram

Figure 23: Diet Coke Can Result Table
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Figure 24: Diet Coke Bottle Chromatogram

Figure 25: Diet Coke Bottle Result Table
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Figure 26: Diet Dr. Pepper Can Chromatogram

Figure 27: Diet Dr. Pepper Can Result Table
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Figure 28: Diet Dr. Pepper Bottle Chromatogram

Figure 29: Diet Dr. Pepper Bottle Result Table
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Figure 30: Diet Coke Can Heat Chromatogram

Figure 31: Diet Coke Can Heat Result Table
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Figure 32: Diet Coke Bottle Heat Chromatogram

Figure 33: Diet Coke Bottle Heat Result Table
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Figure 34: Diet Dr. Pepper Can Heat Chromatogram

Figure 35: Diet Dr. Pepper Can Heat Result Table
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Figure 36: Diet Dr. Pepper Bottle Heat Chromatogram

Figure 37: Diet Dr. Pepper Bottle Heat Result Table

Discussion
Retention time was kept as close as possible since it is necessary to identify compounds
being extracted. Standard 1 had the longest retention time of 9 minutes while all others
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stayed between 6.5 - 8 minutes. When the soda samples were run, the peaks found in this
time range were also identified as aspartame and the peak area was used to calculate
aspartame concentration.
According to the manufacturer’s information Diet Coke in a can should contain
approximately 187.50 mg, while Diet coke in a bottle should have about 264.06 mg. In
the case of Diet Dr. Pepper, a can should contain 184.50 mg and a bottle should have
259.84 mg. The results were that all soda samples had less aspartame concentrations than
what was listed on the company’s website. Aspartame is known to be very stable in solid
form, however, aqueous solutions may cause breakdown to occur. This could be the
reason why the concentrations did not match well with what each company provided.
The second part of this experiment was researching the effects of aspartame when
exposed to prolonged periods of high heat. Since aspartame breaks down in higher
temperatures and in aqueous solutions, I hypothesized that less aspartame would be
detected in the samples exposed to 50 °C. This again was the answer that the data agreed
with. Not only did the aspartame breaks down more than I originally thought it would,
there were also two samples that had smaller peaks areas thus lower concentrations than
the standards I created. This could be a cause for error to occur. More research should be
done.
There are a few errors that did arise during testing. As you can see in Figures 18 and 19,
no result table or peak resulted from running Standard 4 (0.001 M) through the HPLC. I
believed this might have been human error so a third run was conducted to account for
this mishap. Another error occurred when testing the Diet Dr. Pepper can exposed to
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heat. The resulting peak area was 30 times that of the next highest peak area (184 vs. 6
mV*s). Retention time is to blame for this result; all other retention times were in the 7.5
range and DDPCH had a retention time of 6.8 minutes. Since retention time is crucial in
this experiment, this seems to be the logical conclusion as to why the peak area of
DDPCH was higher than any other peak area including the same sample that was not
exposed to heat.
These results show that just 30 days of high heat exposure to diet sodas containing
aspartame can cause a tremendous breakdown to occur. There are controversies
surrounding aspartame and its breakdown products such as phenylalanine, methanol, and
eventually formaldehyde. This experiment highlights a potential problem when diet sodas
are not stored in a temperature regulated environment.
Finally I would like to use this experiment as a call to have diet soda brands label the
amount of aspartame used in their drinks. It was difficult to find information on the
amounts of aspartame present. I believe that with the worry of PKU sufferers and others
trying to avoid aspartame, it would be a logical idea to provide the aspartame amounts on
all drinks similar to how caffeine or sugar itself is labeled on the Nutrition Facts.

CONCLUSION
Aspartame, the most tested artificial sweetener in FDA history is still deemed to be safe
for human consumption. Although it has had a life plagued with controversy, it still
remains one of the most used sweeteners in the world. There are people who have
allergies where they cannot metabolize the phenylalanine by products of aspartame
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breakdown, so any food, beverage, or drug that contains aspartame must have a warning
labeled printed on the packaging.
In conclusion, aspartame breaks down over time in aqueous solutions and the break down
is faster when exposed to high temperatures. The experimental results coincided with
these statements. When Diet Coke and Diet Dr. Pepper were exposed to 50 °C for 37
days, more than 5 times the original concentration of aspartame broke down compared to
samples left at room temperature. This rapid decrease in aspartame concentration over a
short period of time should continue to be tested to see whether large doses of harmful
chemicals are being ingested when the sodas are consumed. Finally diet sodas should
carry a label representing the amount of aspartame added to each drink to help people
with PKU in order to keep track of the amount of phenylalanine they are consuming
daily. Since we can track calories, fat, sugar, and caffeine we ingest in these sodas, we
should also be able to track the artificial sweeteners used to sweeten our diet beverages.

LITERATURE REVIEW
In a compilation study done by B.A. Magnuson, extensive investigations were
done on the use of aspartame in both human and animal trials before being available to
the public for consumption. Various tests included Biochemical effects, Animal and
Human studies regarding the absorption, distribution, metabolism, and elimination of
aspartame and its byproducts, and neurotoxicity studies. This study compiles various
results into a comprehensive look at many aspects and common complaints regarding
aspartame consumption. The overall theme from this study is that more than 90% of all
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subjects had no serious reactions towards the aspartame whether it is neurological or
physical. A common response when reacting to aspartame was headaches; however no
substantial evidence was found in any studies present in the compilation. A main focus of
this study was to look at the maximum allotted daily intake (ADI) of aspartame and how
plausible the chance of exceeding that level would be. From their data, it was shown that
only by replacing all sugar substitutes with aspartame, having maximum allotted levels of
aspartame in the foods, and that the normal intake was by the worst diabetic group being
studied, that the ADI of aspartame would be exceeded by roughly 14%. This is highly
unlikely and most if not all groups fall well below the daily limit.1
A study that argues against the notion that aspartame is relatively safe for
consumption is found in Aspartame (Nutrasweet®): Is it Safe? This book focuses on the
few cases regarding the negative effects of aspartame on humans. Dr. H. J. Roberts is
trying to emphasize the idea that even though these cases seem few and far between,
there are more that are confirmed than there are approximated by the current FDA
warnings and labels. He highlights multiple studies with patients of his own who had
severe reactions towards aspartame. One in particular, talks of a girl who has seizures
after consuming products containing aspartame. Her allergy is confirmed after finding
history of phenylalanine intolerance in other family members and eliminating the
substance from her diet before introducing a small amount back in. This doctor argues
that the labelling of aspartame by the FDA and by food and beverage companies is
skewed. He suggests that all products containing this chemical are to be labelled with the
amount of aspartame as well as a suggested expiration date. The expiration date is to help
remove products that have been stored at too high of temperatures or that have been on
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the shelves for far too long. According to this source, the ADI was increased from 20
mg/kg to 50 mg/kg by the FDA. One kilogram is roughly 2.2 pounds. A person would
have to drink 4-5 liters of diet soda in one day to reach this limit. This limit was created
by being based on animal testing not on human subjects. This number identifies the
maximum daily level of aspartame a person should consume. In reality the ADI is based
on the lifetimes of these animals tested. What Dr. Roberts argues is that the ADI limit
should be much less than it is currently because of a variance of tolerance levels
associated with aspartame. Some of his patients and studies had extreme symptoms from
small amounts, whereas others could ingest larger amounts and would then experience
symptoms.
Dr. Roberts argues that the safety in the consumption of aspartame has been
disquieted by false information from government agencies, skewed test results from
testing, and overall false assurance that aspartame is harmless when ingested. These stem
from his own personal experiences with individuals who have had reactions toward
aspartame and its components. His views contradict guidelines from the FDA. He does
not believe that the information provided by their agency is correct or viable, but is
instead, a false claim based on the large studies without focusing on the small cases that
arise in some individuals.9
In an evaluation of aspartame edited by four Monsanto scientists, studies were
conducted on the effects of aspartame on normal adults and potentially sensitive persons,
safety evaluation in pregnancy, tolerance in various individuals, as well as evaluations of
medical complaints. This source agrees on the FDA’s ADI for aspartame which is 50
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mg/kg body weight. It clarifies that issues were raised involving the various topics above
and that because of these concerns, they were more thoroughly investigated.
For the effects on normal adults, phenylalanine concentrations did not exceed
levels associated with adverse effects even after a consumption of 200 mg/kg body
weight. When consuming aspartame, the research in this study claim that consuming one
large dose of aspartame in a given period causes less build up than small amounts
throughout the day. Also indicated in this study is that dietary proteins can control the
rise of the phenylalanine concentration in individuals. Their overall conclusion for
normal adult humans is that there are no potentially adverse effects with the use of
aspartame; even when consuming large doses, the phenylalanine and methanol levels in
test subjects were below cautionary levels.
Sensitive persons were also tested with varying amounts of aspartame anywhere
from 34 mg/kg to a maximum of 100 mg/kg. From this testing, it was shown that infants
were able to metabolize the aspartame similarly to normal adults. For persons with
sensitivities to phenylalanine, the same various aspartame concentrations were
administered and found to be excreted at half the rate of normal adults. These results
were from one large single dose of the aspartame. Other cases used multiple small doses
given over a time period. What this study failed to demonstrate clearly was the reactions
caused from the elevated plasma phenylalanine concentrations. The levels found present
in patients were highly studied however. Adverse effects on pregnant women were also
studied although no apparent consensus was reached on whether or not there were any
problematic symptoms from the ingestion of aspartame. Though these studies all focused
on the rises in phenylalanine concentrations, so far none have offered a procedure to test
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for the aspartame concentrations found in humans, or in food or drink containing
aspartame.16
Many procedures that do highlight the techniques for identification of the
concentrations of aspartame list the use of a High Performance Liquid Chromatography
(HPLC). The Center for Disease Control (CDC) has a method to identify the
concentrations of aspartame found in liquids using HPLC. The unknown sample is
measured and the absorbance is found. Standards that have known concentrations of
aspartame are also measured using the HPLC and a calibration curve is created. The
absorbance from the unknown sample is then fitted to the linear equation and a
concentration is calculated. Based on the initial volume of the sample, an estimate of the
amount of aspartame present can be determined. This procedure uses chemicals easily
available to a common college chemistry lab. Two eluents will need to be mixed up and
each sampling pump will need to be calibrated before sampling can occur. This source
also identifies certain standard values it chose and these results can be compared to
personal data.17
In a study done by Bernard F. Gibbs, HPLC was used to determine metabolites
and aspartame in foods. These foods included Diet Coke, Diet Pepsi, and Diet Minute
Maid as well as pudding mix and hot chocolate powder. The liquids were eluted with a
water-acetonitrile solution and monitored at 210 nm. From their results, the diet drink
concentrations were similar in comparison with the manufacturer’s listed amounts. These
concentrations were found in the millimolar or the microgram range. Some problems
occurred from interferences from dyes, flavors or other sweeteners. This is a drawback
when using rapid chromatographic methods.2
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According to Adverse Reactions to Food by Therese Beaudette, Aspartame is
classified as a food additive although technically sweeteners are flavors. Ms. Beaudette
highlights that although there have been many questions regarding the safety; it has been
the most voluntarily consumed synthetic chemical. Some of the problems reported from
aspartame use include headache, dizziness, mood alterations, gastrointestinal
disturbances, dermatologic symptoms and menstrual changes. These complaints were
assessed by the CDC and were deemed not a major concern to the greater population
although some individuals may experience these symptoms. While aspartame is
considered safe, conflicting studies have been brought to attention over the major effect
caused from consumption of aspartame, such as headaches. A group of studies concluded
that headache incidences after aspartame ingestion were not comparatively different than
headache incidences after placebo ingestion. Other studies gathered evidence that showed
headache frequency increased during aspartame and stayed relatively constant with
placebo.
A survey was taken to compare headache frequency between caffeine, aspartame,
and alcohol. The responders indicated that aspartame caused headaches significantly
more than caffeine did but less than alcohol. From this data, a conclusion was reached
that labelled aspartame as a possible probable cause for headaches in some consumers.
When concerns were raised about the phenylalanine component, this article just quotes
what the FDA guidelines are and that some physicians have been arguing to not only put
a PKU warning on products containing aspartame, but also the milligram content. From
the conclusion of this article, it is apparent that no particular side of the aspartame
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controversy has been taken and that both sides have ideas that may be beneficial for the
general public.18
Dr. Joseph Mercola and Dr. Kendra Pearsall have published a book called Sweet
Deception which documents the health problems related to highly refined sugar and
artificially produced sweeteners. According to their research over four billion gallons of
diet sodas are being sold every year. These beverages can contain one or a blend of
artificial sweeteners so the actual number of diet sodas being sold that contains aspartame
is not known. In 1958 an amendment requiring the premarket proof of safety was
introduced by the FDA; aspartame was the first of the artificial sweeteners to be placed
under that amendment. Dr. Mercola argues that large-scale human studies have yet to be
conducted so the general safety of aspartame and other artificial sweeteners is only
limited to the toxicological animal data that is required for FDA approval. This is one
main concern found throughout all independent studies that disagree with the FDA’s
approval of aspartame.19
According to this book, adverse reactions to aspartame had the most reports to the
FDA than all other food additives combined besides Olestra. In 1988, 80% of the food
additive complaints to the FDA were about the various aspartame products. Since
aspartame can be fully metabolized in the body compared to Splenda or other sweeteners,
more complications can occur. In 1967 during early stage testing in the safety of
aspartame, multiple red flags appeared. Some side effects recorded from animals studies
included potential neurotoxicity, defects of the brain, seizures, and even death. These
findings were swept under the rug by the G.D. Searle Company and instead the company
produced over 100 studies that showed the safety of their product. These verdicts were
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brought before the FDA in 1973, however, aspartame was not fully FDA approved until
1981. This was the first time where a food manufacturer had a criminal investigation
requested by the FDA. In a crazy plot twist, the lead U.S. attorney for this investigation
not only quit, but began working for G.D. Searle’s law firm. From this main event, there
was no indictment, however, in 1979 The Public Board of Inquiry declared that
aspartame should not be approved because of the potential brain tumors found in animal
test subjects.
The most horrific account in this book regarding the so-called studies performed
by G. D. Searle scientists was that they knowingly falsified results. Comparing original
observations and final observations received by the FDA, it was shown that there were
errors and inconsistencies throughout the studies. These findings were highlighted by the
Bressler Report. Other warnings also came to light when lymph nodes that swelled to
extreme sizes were deemed normal swelling sizes. It was quoted that the data was
obviously not normal and the amount covered up was tremendous. Although these
findings did slow the aspartame approval by the FDA, this book suggests that the CEO of
G. D. Searle used political power to remove people who disapproved of aspartame.
Because of this, an internal panel that originally had a 3 to 2 vote on banning aspartame
was given an extra member who tied the verdict. This tie was broke by the new FDA
commissioner Dr. Hayes; as a side not, Dr. Hayes entered a job with the G. D. Searle
Company not long after aspartame was approved by the FDA.19
After only one year of aspartame’s approval in soft drinks, the FDA had received
over 600 consumer complaints concerning side effects such as headaches and dizziness.
The CDC reviewed part of these complaints and reported that neurological and
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behavioral problems caused by aspartame needed further study before any definite
conclusions could be made. The author from here on becomes a bit biased and critiques
Frederick Trowbridge of the CDC use of the words “mild nature” to describe the
complaints that arose at that time. Dr. Mercola believes that the CDC misidentified the
actual severity of the cases.
A concern that arises when aspartame studies are brought before the FDA is
where the funding is coming from. Dr. Mercola identifies that out of 166 articles from
1980 to 1985, seventy-four were financed by their industry. Of those, 100% indicated the
safety of the sweetener. The other ninety-two articles were independently funded and
showed that 91% of the data showed problematic health effects. Based on these results, it
seems apparent that depending on which group funds the research, the results are skewed
more to what the donor wants to be found. More research is needed before true
conclusions can be determined.
A final argument on flaws found in the G.D. Searle’s aspartame research was the
use of this chemical in powdered form, not in products. Dr. Mercola states that through
this form of testing, results could become flawed or skewed. Any food that is combined
with aspartame can have potential modifications.19 One such example is the breakdown
of aspartame in diet sodas under high temperatures. These unstable conditions have not
been properly tested and therefore consumers may have more health concerns after
aspartame has reacted with such foods. Because of this distinct situation, the research I
will be conducting will focus not only the quantification of aspartame in diet sodas; it
will also highlight any differences when these samples are exposed to temperature levels
where aspartame is known to decompose.
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Overall, Sweet Deception highlights problems with the research conducted by
G.D. Searle, the biased results that occur based on who funds the research, and the
overall dangers that these investigations have not necessarily tested for adequately.
Although this book does not offer a means to test for the safety of aspartame, it does
outline the problems in such a way that procedures can be designed for proper testing.19
In the third edition of Alternative Sweeteners edited by Lyn O’Brien Nabors, the
overall history, characteristics, applications, and safety of aspartame is summarized. As
with all of the other resources mentioned previously, the date of discovery and the uses of
this chemical are all in agreement. This book does have a slight bias towards the notion
that aspartame is not inherently toxic to humans. Only two cases are highlighted that
point to this idea; One is the allegations of brain tumors becoming more prevalent since
the use of aspartame are false, and the other is that the internet misinforms the general
public.
In the case of alleged brain tumors, Alternative Sweeteners argues that a report
from John Olney stating the increase of brain tumors from aspartame is false. Mr. Olney
assumes that only aspartame was the factor that caused the dramatic increase in brain
tumors in a period of four years. Ms. Nabors highlights the data showing that brain
tumors rates were increasing before aspartame was introduced to the general public and
that the patients having these tumors were in old age whereas the majority of aspartame
drinkers were significantly younger. The consensus from the United States,
Australia/New Zealand, the United Kingdom, and the European Union is that aspartame
does not cause cancer. From this information it appears that Mr. Olney may have data
that is considered flawed.
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Ms. Nabors also identifies that use of the internet as a way for the general public
to become misinformed. In the day of the internet, any person can write about any topic
whether they have the necessary knowledge or not. False allegations have arisen
regarding aspartame and many other products. Although seemingly harmless, the articles
more than likely do not contain any scientific evidence or citations. This misinformation
on the internet has been acknowledged by the FDA and they have concluded that no
reliable scientific evidence is present concerning the danger from aspartame. Overall,
more than one hundred countries including the United States have deemed the artificial
sweetener aspartame safe for human consumption.20
According to Politically Incorrect Nutrition by Michael Barbee, the food industry
is nothing more than propaganda that is used to make the general public believe that what
they are consuming is not harmful to their health. This book states that the general public
is too unwilling to consider that the FDA is not as pro health as they seem. It argues that
since aspartame breaks down into methanol, aspartic acid and phenylalanine, the danger
is not in the amount of aspartame taken in, but the amount of the three components.
While the FDA had an ADI of 50 mg/kg body weight for aspartame, the Environmental
Protection Agency (EPA) has the maximum safety limit for methanol set to 7.8 mg per
day. One liter of a diet soda contains roughly 56 mg of methanol and therefore causes
concerns. Another cause of worry among consumers and this book is the chance that the
use of aspartame increases brain cancer rates. Whereas Alternative Sweeteners states that
Mr. Olney had data that was not stable, Politically Incorrect Nutrition claims that Mr.
Olney was indeed correct in his findings. The outcomes showed that between 1984 and
1985 there was a 10% increase in the incidence of brain cancer. The development of
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brain cancer in animal test subjects was one of the main holdbacks for the FDA allowing
aspartame to be consumed by the general public. It was shown that when aspartame
broke down into diketopiperazine (DKP), a brain-tumor agent, the animals began to
develop brain tumors.
Mr. Olney does agree that brain cancer rates did appear to rise in 1973, which was
before the introduction of aspartame. He states that with the sudden spike of brain tumor
rates in the 1984-1985 period suggests a carcinogen was introduced which would cause
such a dramatic increase to occur. According to the National Soft Drink Association,
aspartame cannot be a carcinogen because it never enters the bloodstream. Mr. Barbee
believes that this statement is false. He does not give an argument or evidence as to why
he believes that the above report is not true. To back the idea that aspartame is not
necessarily as safe as it seems Mr. Barbee cites Dr. Joseph Mercola and the findings
listed in many of his books. According to Dr. Mercola, 167 symptoms and/or reasons to
avoid aspartame are listed by the National Institutes for Health in 1991. Other ideas and
arguments of his are quoted in above paragraphs.
Mr. Barbee ideas and information agree with previous sources that state it took 16
years for aspartame to become FDA approved. He also agrees that G.D. Searle Company
had problematic animal studies and that some were fraudulent. This article also points out
that the FDA did induce an investigation into the validity of the tests conducted by Searle
scientists. The U.S. attorney who was responsible for filing the fraud actually took a
position at the company and therefore, the charges were never placed on G.D. Searle.
This information agrees with previously quoted sources.
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Mr. Barbee believes that aspartame is not a chemical that should be used for
human consumption. He points out hazardous chemical by-products, faulty testing
practices, and a lack of legitimate research as concern for the safety of this product. Most
of his points are taken from the previous sources listed and very little of his own research
was added to this report.21
In Sweeteners and Sugar Alternatives in Food Technology edited by Helen
Mitchell, there is a section discussing the history and safety of aspartame as well as the
other similar artificial sweeteners. This source is unbiased and tries to provide the
information that other references above have already mentioned, however, there is no
discussion on the side opposing the safety of aspartame. An interesting piece of
information that had not been highlighted in previous works is that the Ajinomoto
Company of Japan developed and patented most of the commercial production of
aspartame, even though G.D. Searle originally discovered it. Also noted is that because of
aspartame’s maximum sweetness intensity, it can be used as a sole sweetener and does
not have to be combined with other natural or artificial sweeteners. Comparing stabilities,
aspartame is much more stable in solid form than in liquid. The pH, temperature, and
time are all functions that affect the artificial sweetener. According to this source, the
effect of high temperature on the degradation of aspartame is lessened when the pH of the
solution is kept around 3.5-5 on a 1-14 scale. Although Sweetness and Sugar Alternatives
in Food Technology acknowledges that various factors can affect the perceived
sweetness, these factors are not listed or talked about. Theoretical calculations were
performed for the level of methanol found in a 330 mL can of diet soda. This was done
because aspartame’s decomposition products include methanol which is toxic in certain
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limits. Their results identified 18.3 mg or 0.26 mg/kg body weight of methanol in one
330 mL can. Compared to the toxic level of 200-500 mg/kg body weight, this is very
slight and no cause for concern according to their theoretical calculations. Based on the
information provided by Ms. Mitchell, the safety and information regarding aspartame
agrees with previous sources and adds very little to unknown situations.22

.
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